Saturday, May 25, 2024
Home > City News > Coronary stents’ prices capped

Coronary stents’ prices capped

AK -Affordable Coronary stent -nPhoto 17.02.17Regulations to focus on making healthcare more affordable for all sects of society; Coronary stent prices capped, to bring down cost by about 85%:Union Minister Ananthkumar

Bengaluru: Pursuing Prime Minister, Narendra Modi’s vision of ‘Affordable, Quality Healthcare for All’, we have issued the notification for fixing the ceiling prices of coronary stents, informed Union Minister for Chemicals & Fertilizers and Parliamentary Affairs, Ananthkumar on Friday. The step would bring down the cost of coronary stents by about 85%, the Minister added.
Ananthkumar informed that the ceiling prices of Bare Metal Stents (BMS), having 10% market share, has been capped at Rs. 7,260 and Drug Eluting stents (DES), having 90% market share, at Rs. 29,600. These prices are exclusive of VAT and other local taxes. The Minister further stated that since most of the States have 5% VAT on stents, the MRP of BMS and DES would be Rs.7623 and Rs. 31,080. National Pharmaceutical Pricing Authority (NPPA) which is coming under Minister for Chemicals & Fertilizers has fixed the prices within 60 days as required, he added.
Informing that the step is a major decisive action on theunethical margins charged at each stage in the supply chain of coronary stents, the Minister stated that the new prices are not likely to make much adverse impact on industry. The average MRP in the market for BMS was Rs. 45,000 and for DES Rs. 1,21,000. This has been reduced to Rs. 7623 for BMS and Rs. 31,080 for DES. Thus, based on price reduction, patients will get average benefit of 80-90 thousand per stent resulting into a gross relief of Rs. 4450 crores in one year.
“To protect the interest of public, very strict laws will govern the effectiveness of this initiative. Violations or Deviations by manufacturers and Hospitals from the defined norm will attract cancellation of respective Licenses and will be subject to criminal charge. The excess cost charged will have to be returned to the buyer at an interest rate of 15%. Also the manufacturers should continue manufacturing at the large volumes they have been in the last three years, there must not be a reduced manufacturing of stents as an aftermath of this regulation instigated by the Government.” said Minister Ananthkumar.
“As a part of Modi Government’s focus on delivering affordable healthcare, our focus has been to gradually bring changes to Healthcare Ecosystem in the country to meet all basic needs, we have revised the List of essential drugs to ensure it is meaningful & effective and we have capped prices of 1450 medicines in the list through legally available means. From 99 Jan Oushadhikendras (in May 2014) we are at 777 Jan Oushadhikendras today, with more Kendras to be added going ahead.” He added.
Kumar informed that the Ministry of Health and Family Welfare included Coronary Stents in the National List of Essential Medicines, 2015 (NLEM, 2015) on 19th July 2016 and the Ministry of Chemicals and Fertilizers incorporated Coronary Stents in Schedule I of the Drug Prices Control Order (DPCO), 2013 on 21st December 2016.
Kumar stated that the Ministry, after reviewing the recommendation of Ministry of Health had directed the NPPA to hold multi-stakeholder consultations with industry and industry associations, manufacturers, importers, hospital associations, distributors’ associations, doctors and NGOs and other civil society members for fixing the ceiling prices of coronary stents. All the data provided by industry was put on NPPA website and major options for price fixation and prices put in public domain for consultation. The new ceiling prices decided by the Government have taken into account interests of all the stakeholders.
Cardiovascular Diseases (CVD) are major cause of death in India, about 25% of total deaths. Out of these, 90-95% CVD deaths happen due to coronary artery diseases. As per the report of National Commission on Macroeconomics and Health, prevalence of CAD in India is about 61.5 million as per 2015 report. As per Health Ministry report, more than 3.5 lakh procedures were done in 2015 which used 4.73 lakh stents. In 2016, the figure of cardiac stent must have been above 5 lakhs.
The Minister further stated that the new ceiling prices will promote ‘Make in India’ in a big way and seeing the huge number of patients and future requirement, foreign companies will also try to make in India for cutting costs and remain competitive. Presently market size of India made stents is roughly 30%. Shri Kumar assured that he will write to the Ministry of Health and Family Welfare to keep a check on increase the price of procedure, doctor’s fee and prolong the patients’ stay by hospitals to make up for losses it and also ensure that price reduction is passed on to patients.
What the Doctors say:
Dr.VijayalakahmiBalekundri
Heart attack is no more a rich man’s disease. Due to smoking and stress people of all sections of society are succumbing to heart attack. Stenting of coronaries especially with drug eluting stent has bailed out many lives. Exorbitant cost of the stent was eluding the best treatment for many suffering in India. The central government has done a great service to the have nots by cutting the cost by a whopping 85%!!!! We the professionals congratulate our visionary PM Modiji and Sri AnanthKumarji on this extraordinary step to save the precious lives.
Dr Shashidharbuggi, Director-RGUHS
It is a historic initiative. There is a need for such regulatory measures for other consumables& procedures and ICU charges to provide affordable& quality healthcare
Dr B G Tilak plastic surgeon
To reduce prices of stents by Our PM is a boon to millions of Patients suffering from cardiac problems it is indeed a step taken by Our PM to control corruption in medical & PHARMA industry I wish similar steps are taken in Ortho Implants & other medical devices
Dr. Gomathi, SG Hospital
The move to reduce the cost of stent is greatly appreciated. The poor will benefit from this. Hats off to Sri Anandkumar and Modiji.
Dr. HemachandraSagar
Good is happening under ModiGovt for the poor
Dr. Chetan, NIMHANS
Very good move for to help people to cope with common health condition and farmers benefitted by slash in fertilizer prices. Kudos to Sri Ananthkumarji and Modiji.
Dr. Gangadhar, Director-NIMHANS
Making stents cheaper is an achievement
Dr. Devi Shetty
Congratulations. We are very proud of you sir
Dr GB SATTUR cardiologist
Absolutely true!!! Congratulations to AKJI. It’s s bold political, social, financial and moral decision!!!! Stent deployment had become huge mafia, especially In 5 Star cities
Dr Ganesh, MD-Netradhama Hospital.
This is a great step in reduction of cost of medical devices by Narendra Modiji & Ananth Kumarji which will make medical treatment more affordable for the masses & help indigenous manufactures. Strict quality control of devices will ensure benefits for the public and also satisfy the medical fraternity. Made in India with excellence should be the motto!

Leave a Reply

Your email address will not be published. Required fields are marked *